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A B S T R A C T
Angiosarcoma is a rare disease of the breast with the reported incidence of only 0.04% of all breast malignancies. The
etiology of angiosarcoma remains unknown. It occurs post-mastectomy, in association with chronic lymphedema (Stew-
art-Treves syndrome), or after radiotherapy. We present a patient with angiosarcoma which developed 12 years of the di-
agnosis of breast carcinoma and 8 years of the operative procedure and radiotherapy for disease recurrence. A small
angiomatous lesion of a few mm in size, cytologically suspect of vascular tumor (hemangioma or hemangiopericytoma)
and histopathologically verified to be an atypical vascular lesion, was detected two years before breast enlargement and
cytologic and histologic diagnosis of angiosarcoma. The patient died 15 months of the diagnosis of angiosarcoma, after
two tumor recurrences and intrathoracic cavity invasion.
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Introduction
Malignant tumors of vascular origin are rare malig-
nant soft tissue tumors occurring at various sites1 as ei-
ther a primary or secondary event. Primary angiosar-
coma of the breast is an unusual tumor, accounting for 1
per 1700–2000 primary malignant tumors of this organ2.
Angiosarcoma of breast skin and parenchyma is a rarely
reported complication of irradiation for breast carcino-
ma3. The majority of angiosarcomas are high-grade tu-
mors with a varying degree of nuclear atypia, hyper-
chromatic nuclei, large nucleoli, and frequent mitoses.
Hemorrhage into the surrounding stroma is a common
feature of high-grade angiosarcoma4. Fine needle aspira-
tion, supported by ancillary techniques such as immuno-
histochemistry, enables cytologic diagnosis of angiosar-
coma and differentiates it from a carcinoma recurrence1.
Immunostaining for CD34 is the most frequently em-
ployed marker, along with CD31 as a more sensitive and
specific antigen for endothelial differentiation5. Little
data on the specificity of CD31 on cytologic material are
available.
Case Report
Twelve years before, a 75-year-old patient had under-
gone quadrantectomy for a carcinoma detected in the up-
per lateral quadrant of her left breast. After three years,
cancer recurred in the same breast, which was treated by
partial operation followed by radiotherapy. Eight years
after radiotherapy, a reddish angiomatous lesion of sev-
eral millimeters in size occurred in the lower external
quadrant of the same breast. Fine needle aspiration cy-
tology (FNAC) revealed uniform mesenchymal cells, rais-
ing suspicion of vascular tumor (Figure 1a). Histopa-
thology of the excised tissue indicated atypical vascular
lesion (Figure 1b). Two years later, the patient developed
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abrupt enlargement, induration and thickening of the
entire right breast, again with reddish angiomatous le-
sions of several millimeters in size on the skin. Mammog-
raphy and ultrasonography findings were unspecific, only
Doppler ultrasonography showed abnormal vascular flow.
FNAC revealed strongly cellular smears with atypical
pleomorphic mesenchymal cells (Figure 2a and b) with a
high degree of DNA aneuploidy (Figure 2c), and inten-
sive proliferative activity with a high degree of argy-
rophilic nucleolar organizer region (AgNOR) pleomor-
phism (Figure 2d). On immunocytochemistry, cells were
positive for vimentin, CD34 (Figure 2e) and CD31 (Fig-
ure 2f). The diagnosis of angiosarcoma was made and
histopathologically verified on intraoperative material
obtained on total mammectomy (Figure 2g and h). Wi-
thin a year, the patient was reoperated twice for the same
tumor recurrences, followed by tumor invasion of the
intrathoracic cavity. The patient died within 15 months
of the diagnosis of angiosarcoma.
Discussion
Primary angiosarcoma of the breast is usually diag-
nosed in young women, at age 20–40, in contrast to mam-
mary carcinoma that generally occurs at an older age6.
This primary cancer develops as an ill-defined mass in
the breast. Secondary angiosarcoma is often diagnosed in
women over 40, five to ten years after radiotherapy for
breast cancer. The American Cancer Society states that
angiosarcoma is a very rare complication of breast irra-
diation7. With the general acceptance of lumpectomy,
axillary staging, and radiotherapy as local treatment for
infiltrating breast cancer, an appreciation is evolving for
the spectrum of vascular lesions that occur in the mam-
mary skin after this treatment. Most of these lesions de-
velop within the prior irradiation field after breast con-
servation treatment7. There is usually a long latent period
between radiotherapy and the diagnosis of angiosarcoma
(median 59–90 months)8. Vesoulis and Cunliffe3 report a
case of subareolar epithelioid angiosarcoma arising eight
years after lumpectomy and irradiation of the ipsilateral
breast for infiltrating carcinoma. These data are consis-
tent to our case. Angiosarcoma arising in the irradiated
breast after breast-conserving therapy has been reported
with increasing frequency10. As ever more women un-
dergo breast-conserving therapy, the incidence can be ex-
pected to increase11. Radiographic assistance in reaching
the diagnosis has been limited. Mammography may reveal
skin thickening and/or an ill-defined superficial mass,
but findings are often nonspecific. Nearly 33% of pa-
tients with breast angiosarcomas have negative mammo-
grams12. In our patient, the mammography and ultraso-
nography findings were also nonspecific. Cytologic diag-
nosis of angiosarcoma was made preoperatively. How-
ever, some authors found preoperative diagnosis by aspi-
ration cytology and biopsy to be rather difficult13,14. Chen
et al. report on the biopsy false negative rate of 37%15.
High grade angiosarcomas can be easily confused with
other malignant tumors such as recurrent adenocar-
cinoma, lymphoma, melanoma, liposarcoma and other
sarcomas. Low grade angiosarcomas can be easily con-
fused with atypical vascular lesions (AVL), non-neoplas-
tic lesions such as pseudoangiomatous stromal hyperpla-
sia, and granulation tissue. FNAC and core biopsy may
yield false negative results because the margins of angio-
sarcoma tend to have low-grade changes that may be in-
distinguishable from post-irradiation changes16. It is im-
portant to distinguish AVL from angiosarcoma. Longer
follow up will be necessary to fully characterize the prog-
nostic importance of atypical vascular lesions, but cur-
rently there is no evidence that they represent a precur-
sor to irradiation-induced angiosarcoma17. Atypical vas-
cular lesions at the skin margins of mastectomy may be
predictive of recurrence after angiosarcoma resection7.
In our patient, atypical post-irradiation vascular lesion
was diagnosed by intraoperative biopsy cytology and his-
tology a year before. Post-irradiation vascular tumors do
not only present a therapeutic problem for clinicians, but
also an increasing diagnostic dilemma for pathologists.
The latter viewpoint is supported by the significant clini-
cal and histologic overlap between the two tumors18.
Conclusion
Most cases of breast angiosarcoma may develop as a
complication of radical mastectomy for primary breast
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Fig. 1. a) Atypical post-irradiation vascular lesion: FNA cytology
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Fig. 2. Angiosarcoma: a and b) FNA cytology (May-Grünwald-Giemsa, x1000), c) DNA aneuploidy (Fulgen stain), d) nucleolar
organizer region (AgNOR), e and f) cells immunostained for CD31 and CD34 (LSAB, x1000), g) histopathology (hemalaun-eosin,
x100), and h) histopathology (hemalaun-eosin, x400).
cancer and chronic lymphedema present for many years
(Stewart-Treves syndrome), irradiation-induced angio-
sarcoma after radiotherapy for cancer or preexisting be-
nign lesions as atypical vascular lesions. The majority of
angiosarcomas are high-grade tumors with difficult man-
agement decisions for this aggressive disease. Synchro-
nizing and combining cytologic morphology with other
sophisticated diagnostic procedures to reach an accurate
diagnosis, subtyping and prognosis of this tumor is a true
challenge indeed.
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PRIKAZ SLU^AJA ANGIOSARKOMA DOJKE
S A @ E T A K
Angiosarkom je rijetka bolest dojke s opisanom incidencijom od svega 0,04% svih malignoma dojke. Etiologija je
nepoznata, a javlja se u `ena nakon mamektomije, udru`ena s kroni~nim limfedemom (Stewart-Trevesov sindrome) ili
nakon radijacije. Opisuje se slu~aj bolesnice s angiosarkomom 12 godina nakon dijagnoze karcinoma dojke i 8 godina
nakon operacijskog zahvata zbog recidiva i provedenog zra~enja. Dvije godine prije pove}anja cijele dojke te citolo{ke i
histolo{ke dijagnoze angiosarkoma zabilje`ena je pojava sitne angiomatozne promjene od nekoliko mm s citolo{kom
sumnjom na krvo`ilni tumor (hemangiom ili hemangiopericitom), dok je histopatolo{ka analiza pokazala atipi~nu vas-
kularnu leziju. Bolesnica umire 15 mjeseci od dijagnoze angiosarkoma nakon dva recidiva i prodora tumora u intra-
torakalnu {upljinu.
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